VGYAAN Pharmaceuticals LLC is a privately held specialty pharmaceutical company focused on developing and commercializing clinically critical therapies across a variety of dosage forms and therapeutic categories, including generics and 505(b)(2) drugs.
The company was formed as a direct result of long term collaborations with key industry stakeholders from across the value chain. We are committed to continue collaborating with a wide range of stakeholders as we pursue our journey of providing valuable life-improving drug therapies to patients.
Our name is derived from the Sanskrit words for Science – VGYAAN (विज्ञान) and Knowledge – GYAAN (ज्ञान). We chose VGYAAN as our company name because both science and knowledge are fundamental building blocks of our company.
At this time, we are focused on serving the needs of patients in the United States of America. However, we continue to explore a wide range of partnership models for other markets as well and encourage all potential collaborators to contact us.
The global pharmaceutical industry is going through tremendous changes. Therefore, we believe it is imperative to focus on products and therapies that are clinically critical. We are focused on developing and commercializing therapies across a variety of dosage forms and therapeutic categories, including generics and 505(b)(2) drugs.
Founded by industry veteran Nailesh A. Bhatt, VGYAAN Pharmaceuticals is made up of executives with decades of experience from the pharmaceutical, life sciences, investment banking and strategic advisory industries.
VGYAAN Pharmaceuticals LLC is a privately held company backed by veterans of the pharmaceutical and life sciences industry. If you are interested in learning more about the company or would like to arrange a meeting with the company’s management team, please contact us.